Table 1. Baseline patient characteristics.
Characteristic | |
---|---|
Age, years | |
Median | 60 |
Range | 33–76 |
Sex, number (%) | |
Male | 9 (50%) |
Female | 9 (50%) |
Race, number (%) | |
White | 16 (89%) |
Hispanic | 1 (6%) |
African-American | 1 (6%) |
ECOG performance status | |
0 | 5 (28%) |
1 | 13 (72%) |
Disease stage | |
Locally advanced | 1 (6%) |
Metastatic | 17 (94%) |
Prior therapy | |
Chemotherapy | 16 (89%) |
Radiotherapy | 6 (33%) |
Pancreaticoduodenectomy | 5 (28%) |
Prior number of chemotherapy regimens | |
0 | 2 (11%) |
1 | 3 (17%) |
2 or more | 13 (72%) |
Total number of target lesions | |
1 | 1 (6%) |
2 | 4 (22%) |
3 | 9 (50%) |
>= 4 | 4 (22%) |
BRCA 1/2 mutation status | |
Positive | 2 (11%) |
Unknown | 16 (89%) |
Negative | 0 |